Factors influencing self-management behaviors in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.

Mao-Ting Huang, Jia-Yu Fu, Wen-Ting Yi, Hui-Ling Yan, Yi-Meng Wang, Yun-Shan Chen, Ying Zeng

Abstract readReview

In one paragraph

Review in Preventive medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mao-Ting HuangSchool of Nursing, Hunan Engineering Research Center for Early Diagnosis and Treatment of Liver Cancer, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan Province, China.

Jia-Yu FuDepartment of Gastroenterology, The Second Affiliated Hospital, University of South China, Hengyang, Hunan Province, China.

Wen-Ting YiSchool of Nursing, Hunan Engineering Research Center for Early Diagnosis and Treatment of Liver Cancer, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan Province, China.

Hui-Ling YanSchool of Nursing, Hunan Engineering Research Center for Early Diagnosis and Treatment of Liver Cancer, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan Province, China.

Yi-Meng WangSchool of Nursing, Hunan Engineering Research Center for Early Diagnosis and Treatment of Liver Cancer, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan Province, China.

Yun-Shan ChenSchool of Nursing, Hunan Engineering Research Center for Early Diagnosis and Treatment of Liver Cancer, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan Province, China.

Ying ZengSchool of Nursing, Hunan Engineering Research Center for Early Diagnosis and Treatment of Liver Cancer, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate self-management levels and influencing factors in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) to inform targeted interventions. Methods: A mixed-methods systematic review was conducted following the Joanna Briggs Institute methodology and reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Nine English and Chinese databases were searched from inception to October 28, 2025. Results: Ten studies (8 quantitative, 2 qualitative) were included, all conducted in China ( Conclusions: The self-management of patients with MASLD is a public health priority shaped by the interaction between individual capabilities and broader social determinants. Our findings support integrated public health strategies that enhance individual capabilities, strengthen external support, and bolster motivation to prevent progression of MASLD.

Indexed as

Healthy behaviorInfluencing factorsMetabolic dysfunction-associated Steatotic liver disease (MASLD)Public healthSelf-management

Identifiers

PMID42169713

DOI10.1016/j.pmedr.2026.103490

PMCPMC13188123

What Socratic holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.